Cure Alzheimer's Fund Cure Alzheimer's Fund

Julia Neitzel, Ph.D.

Postdoctoral scientist, Harvard T.H. Chan School of Public Health, Harvard University

Dr. Neitzel’s research interest is to understand why some people are more resilient against age-related cognitive decline and dementia – important, yet missing knowledge which could inform better prevention programs. For addressing this question, she combines her knowledge on cognition and brain imaging gained during her under- and postgraduate studies (TUM & LMU Munich, Germany), with her postdoctoral work on genetic and modifiable risk factors of dementia (LMU; Erasmus MC, Rotterdam, the Netherlands). Her work focuses on the preclinical stage of dementia, where people would most likely benefit from prevention programs.

In 2021, Dr. Neitzel was awarded an EU Marie-Curie postdoctoral fellowship to work with Prof Dr. Albert Hofman (HSPH, Boston, USA) and Prof Dr. Meike Vernooij (Erasmus MC, Rotterdam, NL) to deepen our understanding of how a person’s genetics interact with risk and resilience factors in the development of Alzheimer’s-type brain and cognitive changes. The goal is to identify the best target group for lifestyle intervention programs against dementia.

Twitter: @julia_neitzel

Related Research:

Disentangling the Role of Intracranial Arteriosclerosis in Alzheimer’s Disease Daniel Bos Frank J. Wolters Geert Jan Biessels Julia Neitzel Meike Vernooij 2022-02-10

Funded Research

These projects were made possible from Cure Alzheimer's Fund support.

Project Description Researchers Funding
Disentangling the Role of Intracranial Arteriosclerosis in Alzheimer’s Disease 2021, 2023

$339,258.55

Selected Publications

These published papers resulted from Cure Alzheimer’s Fund support.

Claus, J. J., Vom Hofe, I., van Ijlzinga Veenstra, A., Licher, S., Seelaar, H., de Jong, F. J., Neitzel, J., Vernooij, M. W., Ikram, M. A., & Wolters, F. J. Generalizability of trial criteria on amyloid-lowering therapy against Alzheimer’s disease to individuals with mild cognitive impairment or early Alzheimer’s disease in the general population, European Journal of Epidemiology, March 23, 2025, Read More

Streiber, A. M., Neitzel, J., Nguyen Ho, P. T., Vernooij, M. W., & Bos, D. Intracranial arteriosclerosis is not associated with cerebral amyloid deposition, Alzheimer's & Dementia, October 1, 2024r, Read More

Back to Our Researchers